Dr. Francesca M. Spagnoli, Max Delbrück Center for Molecular Medicine (IMAGE)
Caption
A European Research Council Starting Grant worth more than a million euros over the next five years has been awarded to Dr. Francesca M. Spagnoli of the Max Delbrück Center for Molecular Medicine Berlin-Buch, Germany. For nearly a year Dr. Spagnoli has been leading a Helmholtz junior research group at MDC, an institution of the Helmholtz Association, and at Charité – Universitätsmedizin Berlin. Together with the biophysicist Dr. Leif Schröder from the Leibniz Institut für Molekulare Pharmakologie, also on the Berlin-Buch Campus, Dr. Spagnoli belongs to the 240 top scientists the ERC has chosen from more than 2,500 applicants. The research project of Dr. Spagnoli will investigate the possibility of reprogramming hepatic cells to pancreas cells so that they can ultimately replace the destroyed pancreatic beta cells and produce the vital hormone insulin in diabetic patients.
Credit
Photo: David Ausserhofer/Copyright: MDC
Usage Restrictions
None
License
Licensed content